Thursday, February 23, 2012

Vivus, Inc shares prices feb 23 2012

Vivus, Inc shares prices feb 23 2012 ; Vivus, Inc. (NASDAQ:VVUS) is up 105.31% in pre market trading at $21.59. VVUS shares are soaring today after a FDA advisory panel recommended its drug, Qnexa, for marketing approval.

This recommendation doesn’t guarantee that the FDA will approve the drug, but in most cases the FDA follows the recommendation of its panels. VVUS has already traded its average volume in pre market with 2.3 million shares traded so far. The company has a market cap of 937.71 million.For the latest updates on the stock market, visit Stock Market Today For the latest updates PRESS CTR + D or visit Stock Market news Today

Related Post:

No comments:

Post a Comment